The prevalence of child and adolescent obesity has plateaued at high levels in most high-
income countries and is increasing in many low-income and middle-income countries …

A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors
such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led …

Abstract Background A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-
like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug …

You have in your hands, or at your fingertips, the first edition of the American Academy of
Pediatrics clinical practice guideline for evaluation and management of children and …

Contemporary information on the fraction of cancers that potentially could be prevented is
useful for priority setting in cancer prevention and control. Herein, the authors estimate the …

Childhood obesity has become a global pandemic in developed countries, leading to a host
of medical conditions that contribute to increased morbidity and premature death. The …

Background Obesity is a chronic disease with limited treatment options in pediatric patients.
Liraglutide may be useful for weight management in adolescents with obesity. Methods In …

The prevalence of obesity among children and adolescents (aged 2–18 years) has
increased rapidly, with more than 100 million affected in 2015. Moreover, the epidemic of …

Importance More than 35% of men and 40% of women in the United States are obese.
Obesity is associated with health problems such as increased risk for coronary heart …

This scientific statement presents considerations for clinical management regarding the
assessment and risk reduction of select pediatric populations at high risk for premature …